Opening book details…
About this Medicine article
Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease by Frölich, Lutz; Wunderlich, Glen; Thamer, Claus; Roehrle, Michael; Garcia, Miguel; Dubois, Bruno is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Frölich, Lutz; Wunderlich, Glen; Thamer, Claus; Roehrle, Michael; Garcia, Miguel; Dubois, Bruno
- Publisher
- BioMed Central; Springer (Biomed Central Ltd.); Springer Science and Business Media LLC (ISSN 1758-9193)
- Published
- 2019
- Language
- EN
- Field
- Medicine (Health Sciences)